BioMedPartners Founded 2003
Founders Gerhard Ries
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 66
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 44
Rounds per year 2.44
Lead investments 19
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.36
Exits 16
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Consumer Goods
Health Care
Industrial
Lifestyle
Summary

The venture was found in Europe in Switzerland. The main office of represented VC is situated in the Basel.

The fund was created by Gerhard Ries. We also calculated 4 valuable employees in our database.

The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Anergis, Inotrem, Miracor Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Developer Platform, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. This BioMedPartners works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the BioMedPartners, startups are often financed by Novartis Venture Fund, High-Tech Gru00fcnderfonds, KfW. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, BB Biotech Ventures, Neomed Management. In the next rounds fund is usually obtained by SV Health Investors, Novartis Venture Fund, HBM Healthcare Investments AG.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Topas Therapeutics
Advanced Materials
Biotechnology
Chemical
Chemical Engineering
Early Stage Venture
25M19 Oct 2020 Germany, Hamburg
Tubulis Technologies
Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
Early Stage Venture
12M21 Jul 2020 Germany, Munich
TOLREMO therapeutics
Biotechnology
Pharmaceutical
Early Stage Venture
4M10 Jun 2020 Switzerland, Zurich
Azafaros
Biotechnology
Content
Education
Health Care
Therapeutics
Tutoring
Early Stage Venture
29M06 Feb 2020 China, Songjiang
ImmunOs Therapeutics
Biotechnology
Drug Discovery
Health Care
Pharmaceutical
Early Stage Venture
15M10 Dec 2019 Switzerland, " Switzerland"}
Alentis Therapeutics
Biotechnology
Therapeutics
Early Stage Venture
13M29 Apr 2019 Switzerland, Basel
Precirix
Biotechnology
Early Stage Venture
43M15 Nov 2018 Belgium, City of Brussels
Amal Therapeutics
Biopharma
Biotechnology
Drug Discovery
Life Science
Neuroscience
Therapeutics
Early Stage Venture
34M12 Nov 2018 Switzerland, Geneva
TOLREMO therapeutics
Biotechnology
Pharmaceutical
Early Stage Venture
9M24 Sep 2018 Switzerland, Zurich
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioMedPartners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: